CervoMed Inc. logo

CervoMed Inc.

Canonical company identity and public leadership record.

NASDAQ: CRVOUS

  • Source reported. 26 claims from 3 sources.
  • Not claimed by the company.
  • Eval: not assessed.
Board
8 directorsAlpha calculation. Published seats
Independence
6 of 8Alpha calculation
Committees
5
Evidence
3 sources26 published claims
Last reviewed
Freshness: current
Open conflicts
0None open
Alpha EvalNot assessed. No Eval is published for this company.

Leadership

6 claims
Leadership
PersonRoleSinceStatusEvidence
John AlamPresident and Chief Executive OfficerCurrentSource reportedE3

Stated in the record as John Alam: President and Chief Executive Officer

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:13

Report an error
Kelly BlackburnExecutive Vice President, Clinical DevelopmentCurrentSource reportedE4

Stated in the record as Kelly Blackburn: Executive Vice President, Clinical Development

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:14

Report an error
Marco VerwijsExecutive Vice President, Technical OperationsCurrentSource reportedE5

Stated in the record as Marco Verwijs: Executive Vice President, Technical Operations

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:15

Report an error
Mark De RoschExecutive Vice President, Regulatory and Government Affairs and Program ManagementCurrentSource reportedE6

Stated in the record as Mark De Rosch: Executive Vice President, Regulatory and Government Affairs and Program Management

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:16

Report an error
Matthew WintonChief Commercial and Business OfficerCurrentSource reportedE7

Stated in the record as Matthew Winton: Chief Commercial and Business Officer

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:17

Report an error
William R. ElderChief Financial Officer, General Counsel, Corporate SecretaryCurrentSource reportedE8

Stated in the record as William R. Elder: Chief Financial Officer, General Counsel, Corporate Secretary

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:18

Report an error

Board

8 claims
Board of directors
DirectorStatusSinceCommitteesEvidence
Frank ZavrlIndependentAudit; Audit; Compensation · Chair; Nominating and Governance; Compensation, chair; Nominating and GovernanceSource reportedE2

Stated in the record as Frank Zavrl: Director, Audit; Compensation · Chair; Nominating and Governance

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:5

Report an error
Jane H. Hollingsworth, J.D.IndependentNone publishedSource reportedE2

Stated in the record as Jane H. Hollingsworth, J.D.: Director

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:6

Report an error
Jeff PoultonIndependentAudit, chair; Audit · Chair; Compensation; CompensationSource reportedE2

Stated in the record as Jeff Poulton: Director, Audit · Chair; Compensation

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:7

Report an error
John Alam, M.D.Not independentNone publishedSource reportedE2

Stated in the record as John Alam, M.D.: Director

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:8

Report an error
Joshua S. Boger, Ph.D.IndependentNone publishedSource reportedE2

Stated in the record as Joshua S. Boger, Ph.D.: Director

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:9

Report an error
Marwan Sabbagh, M.D.IndependentNone publishedSource reportedE2

Stated in the record as Marwan Sabbagh, M.D.: Director

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:10

Report an error
Robert J. Cobuzzi, Jr., Ph.D.Not independentNone publishedSource reportedE2

Stated in the record as Robert J. Cobuzzi, Jr., Ph.D.: Director

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:11

Report an error
Sylvie Grégoire, PharmD.IndependentNone publishedSource reportedE2

Stated in the record as Sylvie Grégoire, PharmD.: Director

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:12

Report an error

Committees

8 claims
Committee risk allocation
CommitteeChairMembersRisks assignedEvidence
AuditJeff PoultonJeff Poulton, Frank ZavrlNot described in the published recordSource reportedE9

Stated in the record as Audit: Chair Jeff Poulton; Members Jeff Poulton (Chair); Frank Zavrl

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_record:19

Report an error
Audit · Chair; CompensationNot publishedJeff PoultonNot described in the published record
Audit; Compensation · Chair; Nominating and GovernanceNot publishedFrank ZavrlNot described in the published record
CompensationFrank ZavrlFrank Zavrl, Jeff PoultonNot described in the published recordSource reportedE9

Stated in the record as Compensation: Chair Frank Zavrl; Members Frank Zavrl (Chair); Jeff Poulton

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_record:22

Report an error
Nominating and GovernanceNot publishedFrank ZavrlNot described in the published recordSource reportedE9

Stated in the record as Nominating and Governance: Chair not stated; Members Frank Zavrl

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_record:25

Report an error
Committees and risk ownership: further claims
FactStated valueEvidence
Committee appointmentJeff Poulton: chair, AuditSource reportedE9

Stated in the record as Jeff Poulton: chair, Audit

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_appointment:20

Report an error
Committee appointmentFrank Zavrl: member, AuditSource reportedE9

Stated in the record as Frank Zavrl: member, Audit

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_appointment:21

Report an error
Committee appointmentFrank Zavrl: chair, CompensationSource reportedE9

Stated in the record as Frank Zavrl: chair, Compensation

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_appointment:23

Report an error
Committee appointmentJeff Poulton: member, CompensationSource reportedE9

Stated in the record as Jeff Poulton: member, Compensation

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_appointment:24

Report an error
Committee appointmentFrank Zavrl: member, Nominating and GovernanceSource reportedE9

Stated in the record as Frank Zavrl: member, Nominating and Governance

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_appointment:26

Report an error

Authority

1 claim
Authority to act
FactStated valueValid fromEvidence
Principal executive officerJohn Alam, President and Chief Executive Officer, from Apr 30, 2026Source reportedE3Same claim as above

Stated in the record as John Alam: President and Chief Executive Officer

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:13

Report an error

Not in the public record: who can authorize an agent; ai agents registered by the company; delegations published.

Financial context

1 claim
Financials and market context
FactStated valueEvidence
Security listingCRVO (NASDAQ)Source reportedE1

Stated in the record as CRVO (NASDAQ)

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:security_listing:27

Report an error

Other published claims

3 claims
Other published claims
FactStated valueEvidence
Legal nameCervoMed Inc.Source reportedE1

Stated in the record as CervoMed Inc.

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:legal_name:1

Report an error
Entity statusPublic listing publishedSource reportedE1

Stated in the record as Public listing published

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:entity_status:3

Report an error
Published factUSSource reportedE1

Stated in the record as US

Claim ID alpha:claim:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:published_fact:4

Report an error

Evidence

9 evidence records
Evidence ledger
RefSourceAuthoritySource dateRetrievedRightsCited by
E1Alpha canonical company public projectionCanonical identityOpen webNot recordedRights not recorded, link only4 claims
E2CervoMed Inc. DEF 14A 2025-04-29SEC proxyAuthoritative, regulatory filingRights not recorded, link only8 claims
E3CRVO DEF 14A executive officersSEC filingAuthoritative, regulatory filingRights not recorded, link only1 claim
E4CRVO DEF 14A executive officersSEC filingAuthoritative, regulatory filingRights not recorded, link only1 claim

No evidence record is pinned or signed yet.

Not yet in this record

These parts of a company record have no published claims yet. That is a coverage state, not a finding about the company. 1 further claim is under review.

  • Control and voting
  • Governance
  • Risk
  • AI oversight
  • Compensation

Index memberships

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of 22 Nov 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Coverage states the record reports (12)
Corporate structure
Not reviewed. Parent, subsidiary and predecessor structure explains who is governed.
Ownership
Not reviewed. Ownership and voting power determine who can influence the board.
Financials
Not reviewed. Governance-relevant financial context frames capital and audit decisions.
Compensation
Not reviewed. Pay design shows how incentives are governed.
Governance
Not reviewed. Governing documents and provisions set the rules of the enterprise.
Shareholder governance
Not reviewed. Meeting and vote records show shareholder dissent and support.
Audit
Not reviewed. Auditor, controls and restatements show assurance over reporting.
Legal
Not reviewed. Material legal and regulatory matters show enforcement exposure.
Risk
Not reviewed. Risk ownership links the board, committees, executives and controls.
Cyber
Not reviewed. Cyber and data governance is a disclosed oversight domain.
AI governance
Not reviewed. AI oversight is a differentiated Alpha governance domain.
Markets external
Not reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
Limits of this record (5)
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

History

Version public-1

Published .

  1. CEO role recorded. John Alam executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
  2. Executive appointed. Kelly Blackburn executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
  3. Executive appointed. Marco Verwijs executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
  4. Executive appointed. Mark De Rosch executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
  5. Executive appointed. Matthew Winton executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
  6. CFO role recorded. William R. Elder executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
  7. Director appointed. Joshua S. Boger, Ph.D. seat on CervoMed Inc., effective 2024.Effective . Recorded .
  8. Director appointed. Frank Zavrl seat on CervoMed Inc., effective 2023.Effective . Recorded .
  9. Director appointed. Jeff Poulton seat on CervoMed Inc., effective 2023.Effective . Recorded .
  10. Director appointed. John Alam, M.D. seat on CervoMed Inc., effective 2023.Effective . Recorded .
  11. Director appointed. Marwan Sabbagh, M.D. seat on CervoMed Inc., effective 2023.Effective . Recorded .
  12. Director appointed. Robert J. Cobuzzi, Jr., Ph.D. seat on CervoMed Inc., effective 2023.Effective . Recorded .
  13. Director appointed. Sylvie Grégoire, PharmD. seat on CervoMed Inc., effective 2023.Effective . Recorded .
  14. Committee created. Audit · Chair; Compensation committee of CervoMed Inc., effective 2023.Effective . Recorded .
  15. Committee member added. Jeff Poulton member of Audit · Chair; Compensation, effective 2023.Effective . Recorded .
  16. Committee created. Audit; Compensation · Chair; Nominating and Governance committee of CervoMed Inc., effective 2023.Effective . Recorded .
  17. Committee member added. Frank Zavrl member of Audit; Compensation · Chair; Nominating and Governance, effective 2023.Effective . Recorded .
  18. Director appointed. Jane H. Hollingsworth, J.D. seat on CervoMed Inc., effective 2020.Effective . Recorded .

About this record

Alpha ID
alpha:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc
Version
public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
Identity
Not claimed
Evidence
Source reported
Evaluation
Not assessed
Monitoring
Not monitored yet
Authority
Not published
Freshness
Current
Integrity
Not signed yet
Basis
Published company record built from public sources
Never published
Private company data: deployments, authority grants, TrustChecks, receipts, telemetry

The company can claim this record and correct or dispute any claim. Corrections are versioned and the original stays in history. A company's own statements are shown as its own and never replace the cited evidence.